Nonobese fatty liver disease

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836 · see citing works

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664 · see citing works

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · see citing works

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Vernon, G. C., Baranova, A. V., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,067 · see citing works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890 · see citing works

Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome

Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,676 · see citing works

Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,413 · see citing works

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302 · see citing works

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Chalasani, N., Younossi, Z. M., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K. J., Charlton, M., & Sanyal, A. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.001 · Cited by 1,773 · see citing works

The Obese Without Cardiometabolic Risk Factor Clustering and the Normal Weight With Cardiometabolic Risk Factor Clustering: Prevalence and Correlates of 2 Phenotypes Among the US Population (NHANES 1999-2004)

Wildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618 · see citing works

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Shah, A. G., Lydecker, A. D., Murray, K. F., Tetri, B., Contos, M. J., & Sanyal, A. J. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.033 · Cited by 1,561 · see citing works

Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease

Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322 · see citing works

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2010) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,285 · see citing works

Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,261 · see citing works

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234 · see citing works

Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations

Castéra, L., Foucher, J., Bernard, P., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2009) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,157 · see citing works

Identification and characterization of metabolically benign obesity in humans

Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · see citing works

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D., & Day, C. P. (2010) · Gut · doi:10.1136/gut.2010.216077 · Cited by 946 · see citing works

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

Sookoian, S. C., & Pirola, C. J. (2011) · Hepatology · doi:10.1002/hep.24283 · Cited by 917 · see citing works

Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications

Cusi, K. J. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.003 · Cited by 912 · see citing works

The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation

Hamaguchi, M., Kojima, T., Itoh, Y., Harano, Y., Fujii, K., Nakajima, T., Kato, T., Takeda, N., Okuda, J., Ida, K., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01526.x · Cited by 908 · see citing works

The metabolically obese, normal-weight individual revisited.

Ruderman, N., Chisholm, D., Pi-Sunyer, X., & Schneider, S. (1998) · Diabetes · doi:10.2337/diabetes.47.5.699 · Cited by 893 · see citing works

The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults

Clark, J. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000168638.84840.ff · Cited by 804 · see citing works

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

Kim, D., Kim, R. W., Kim, H. J., & Therneau, T. M. (2013) · Hepatology · doi:10.1002/hep.26156 · Cited by 772 · see citing works

Dietary Habits and Their Relations to Insulin Resistance and Postprandial Lipemia in Nonalcoholic Steatohepatitis

Musso, G., Gambino, R., Michieli, F. D., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 758 · see citing works

Metabolic and Body Composition Factors in Subgroups of Obesity: What Do We Know?

Karelis, A. D., St-Pierre, D. H., Conus, F., RABASA-LHORET, R. P. R., & Poehlman, É. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0165 · Cited by 722 · see citing works

Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†

Valenti, L., Al‐Serri, A., Daly, A. K., Galmozzi, E., Rametta, R., Dongiovanni, P., Nobili, V., Mozzi, E., Roviaro, G., Vanni, E., et al. (2010) · Hepatology · doi:10.1002/hep.23622 · Cited by 651 · see citing works

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

Younossi, Z. M., Stepanova, M., Rafiq, N., Makhlouf, H. R., Younoszai, Z., Agrawal, R., & Goodman, Z. D. (2011) · Hepatology · doi:10.1002/hep.24268 · Cited by 636 · see citing works

Visceral fat: A key mediator of steatohepatitis in metabolic liver disease

van der Poorten, D. K., Milner, K.-L., Hui, J., Hodge, A., Trenell, M., Kench, J., London, R., Peduto, T., Chisholm, D. J., & George, J. (2008) · Hepatology · doi:10.1002/hep.22350 · Cited by 633 · see citing works

The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals

Blüher, M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346ccc · Cited by 632 · see citing works

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., Allison, M. E. D., Alexander, G. J., Piguet, A.-C., Anty, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5309 · Cited by 623 · see citing works

Hepatic histology in obese patients undergoing bariatric surgery

Machado, M. V., Marques-Vidal, P. M., & Cortez‐Pinto, H. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.06.013 · Cited by 577 · see citing works

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

Younossi, Z. M., Stepanova, M., Negro, F., Hallaji, S., Younossi, Y., Lam, B. P., & Srishord, M. K. (2012) · Medicine · doi:10.1097/md.0b013e3182779d49 · Cited by 554 · see citing works

Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

Liu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A.-C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.030 · Cited by 549 · see citing works

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study

Zelber‐Sagi, S., Nitzan, D., Goldsmith, R., Webb, M., Blendis, L. M., Halpern, Z., & Oren, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.06.020 · Cited by 545 · see citing works

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

Dongiovanni, P., Petta, S., Maglio, C., Fracanzani, A. L., Pipitone, R., Mozzi, E., Motta, B. M., Kaminska, D., Rametta, R., Grimaudo, S., et al. (2015) · Hepatology · doi:10.1002/hep.27490 · Cited by 533 · see citing works

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529 · see citing works

Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

Farrell, G. C., Chitturi, S., Lau, G. K. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 518 · see citing works

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet

Matsuzawa, N., Takamura, T., Kurita, S., Misu, H., Ota, T., Ando, H., Yokoyama, M., Honda, M., Zen, Y., Nakanuma, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21874 · Cited by 516 · see citing works

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†

Wouters, K., van Gorp, P. J., Bieghs, V., Gijbels, M. J., Duimel, H., Lütjohann, D., Kerksiek, A., van Kruchten, R., Maeda, N., Staels, B., et al. (2008) · Hepatology · doi:10.1002/hep.22363 · Cited by 477 · see citing works

The Association of Genetic Variability in Patatin-Like Phospholipase Domain-Containing Protein 3 (PNPLA3) with Histological Severity of Nonalcoholic Fatty Liver Disease†

Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E., & Liang, J. T. (2010) · Hepatology · doi:10.1002/hep.23759 · Cited by 473 · see citing works

Nonobese Population in A Developing Country Has A High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease

Das, K., Das, K., Mukherjee, P. S., Ghosh, A., Ghosh, S., Mridha, A. R., Dhibar, T., Bhattacharya, B., Bhattacharya, D. K., Manna, B., et al. (2010) · Hepatology · doi:10.1002/hep.23567 · Cited by 469 · see citing works

Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity

McLaughlin, T., Lamendola, C., Liu, A., & Abbasi, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0615 · Cited by 468 · see citing works

Heritability of Nonalcoholic Fatty Liver Disease

Schwimmer, J. B., Celedon, M. A., Lavine, J. E., Salem, R. M., Campbell, N. V., Schork, N. J., Shiehmorteza, M., Yokoo, T., Chavez, A. D., Middleton, M. S., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.050 · Cited by 464 · see citing works

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease

Lomonaco, R., Ortiz‐Lopez, C., Orsak, B., Webb, A., Hardies, J., Darland, C., Finch, J., Gastaldelli, A., Harrison, S. A., Tio, F. O., et al. (2011) · Hepatology · doi:10.1002/hep.25539 · Cited by 461 · see citing works

Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity

Nazare, J., Smith, J. D., Borel, A., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.035758 · Cited by 440 · see citing works

Early Detection of Nonalcoholic Steatohepatitis in Patients with Nonalcoholic Fatty Liver Disease by Using MR Elastography

Chen, J., Talwalkar, J. A., Yin, M., Glaser, K. J., Sanderson, S. O., & Ehman, R. L. (2011) · Radiology · doi:10.1148/radiol.11101942 · Cited by 434 · see citing works

Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults

Kim, H. J., Kim, H. J., Lee, K. E., Kim, D. J., Kim, S. K., Ahn, C. W., Lim, S., Kim, K. R., Lee, H. C., Huh, K. B., et al. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2169 · Cited by 434 · see citing works

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis†

Nobili, V., Vizzutti, F., Arena, U., Abraldeṣ, J. G., Marra, F., Pietrobattista, A., Fruhwirth, R., Marcellini, M., & Pinzani, M. (2008) · Hepatology · doi:10.1002/hep.22376 · Cited by 429 · see citing works

Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults

PARK, S. H., Jeon, W. K., KIM, S. H., Kim, H. J., Park, D. I., Cho, Y. K., Sung, I. K., Sohn, C. I., Keum, D. K., & KIM, B. I. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04086.x · Cited by 421 · see citing works

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

Musso, G., Gambino, R., & Cassader, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.11.002 · Cited by 410 · see citing works

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

Fan, J., Zhu, J., Li, X., Chen, L., Li, L., Dai, F., Li, F., & Chen, S. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.042 · Cited by 403 · see citing works

TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content

Mahdessian, H., Taxiarchis, A., Popov, S., Silveira, A., Franco-Cereceda, A., Hamsten, A., Eriksson, P., & van't Hooft, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323785111 · Cited by 369 · see citing works

Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH

Caballero, F., Fernández, A., De Lacy, A. M., Fernández-Checa, J. C., Caballería, J., & García-Ruiz, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.016 · Cited by 368 · see citing works

PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡

Speliotes, E. K., Butler, J. L., Palmer, C. D., Voight, B. F., & Hirschhorn, J. N. (2010) · Hepatology · doi:10.1002/hep.23768 · Cited by 362 · see citing works

The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis

Singal, A. G., Manjunath, H., Yopp, A. C., Beg, M. S., Marrero, J. A., Gopal, P., & Waljee, A. K. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.476 · Cited by 361 · see citing works

Waist circumference and abdominal adipose tissue distribution: influence of age and sex

Kuk, J. L., Lee, S., Heymsfield, S. B., & Ross, R. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1330 · Cited by 354 · see citing works

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

Leung, J. C., Loong, T. C., Wei, J. L., Wong, G. L., Chan, A. W. H., Choi, P. C., Shu, S. S., Chim, A. M., Chan, H. L., & Wong, V. W. (2016) · Hepatology · doi:10.1002/hep.28697 · Cited by 348 · see citing works

Community-based lifestyle modification programme for non-alcoholic fatty liver disease: A randomized controlled trial

Wong, V. W., Chan, R., Wong, G. L., Cheung, B., Chu, C. W., Yeung, D. K., Chim, A. M., Lai, J. W.-Y., Li, L. S., Sea, M. M.-M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.013 · Cited by 346 · see citing works

Ezetimibe for the treatment of nonalcoholic steatohepatitis: Assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

Loomba, R. S., Sirlin, C. B., Ang, B., Bettencourt, R., Jain, R., Salotti, J., Soaft, L., Hooker, J. C., Kono, Y., Bhatt, A., et al. (2014) · Hepatology · doi:10.1002/hep.27647 · Cited by 346 · see citing works

Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diabetic Patients

Tamura, Y., Tanaka, Y., Sato, F., Choi, J. B., Watada, H., Niwa, M., Kinoshita, J., Ooka, A., Kumashiro, N., Igarashi, Y., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1959 · Cited by 334 · see citing works

Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors

Assy, N., Nasser, G., Kamayse, I., Nseir, W., Beniashvili, Z., Djibre, A., & Grosovski, M. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/810961 · Cited by 331 · see citing works

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy

Wei, J. L., Leung, J. C., Loong, T. C., Wong, G. L., Yeung, D. K., Chan, R., Chan, H. L., Chim, A. M., Woo, J., Chu, C. W., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.235 · Cited by 317 · see citing works

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

Stepanova, M., Rafiq, N., & Younossi, Z. M. (2010) · Gut · doi:10.1136/gut.2010.213553 · Cited by 301 · see citing works

Role of leisure-time physical activity in nonalcoholic fatty liver disease: A population-based study

Zelber-Sagi, S., Nitzan-Kaluski, D., Goldsmith, R., Webb, M., Zvibel, I., Goldiner, I., Blendis, L., Halpern, Z., & Oren, R. (2008) · Hepatology · doi:10.1002/hep.22525 · Cited by 296 · see citing works

Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review

Freedland, E. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-12 · Cited by 296 · see citing works

Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults

Chen, C., Huang, M., Yang, J.-C., Nien, C., Yang, C., Yeh, Y., & Yueh, S.-K. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200609000-00016 · Cited by 294 · see citing works

Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome

Abid, A., Taha, O., Nseir, W., Farah, R. E., Grosovski, M., & Assy, N. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.033 · Cited by 288 · see citing works

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease

Eguchi, Y., Eguchi, T., Mizuta, T., Ide, Y., Yasutake, T., Iwakiri, R., Hisatomi, A., Ozaki, I., Yamamoto, K., Kitajima, Y., et al. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1790-5 · Cited by 278 · see citing works

Fatty liver in non‐alcoholic non‐overweight Japanese adults: Incidence and clinical characteristics

Omagari, K., Kadokawa, Y., Masuda, J., Egawa, I., Sawa, T., Hazama, H., Ohba, K., Isomoto, H., Mizuta, Y., Hayashida, K., et al. (2002) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2002.02846.x · Cited by 275 · see citing works

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

Zelber‐Sagi, S., Lotan, R., Shlomai, A., Webb, M., Harrari, G., Buch, A., Nitzan, D., Halpern, Z., & Oren, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.011 · Cited by 274 · see citing works

Gender-Specific Differences in Adipose Distribution and Adipocytokines Influence Adolescent Nonalcoholic Fatty Liver Disease Δ

Ayonrinde, O. T., Olynyk, J. K., Beilin, L. J., Mori, T. A., Pennell, C. E., de Klerk, N. H., Oddy, W. H., Shipman, P. J., & Adams, L. A. (2010) · Hepatology · doi:10.1002/hep.24097 · Cited by 238 · see citing works

Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance

Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E. C., Murashima, S., Maruyama, N., Morioka, K., Nakatani, K., Yano, Y., & Adachi, Y. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2341 · Cited by 234 · see citing works

Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography

Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., & Ehman, R. L. (2013) · Radiology · doi:10.1148/radiol.13121193 · Cited by 229 · see citing works

Association of Nonalcoholic Fatty Liver Disease With Components of Metabolic Syndrome According to Body Mass Index in Korean Adults

Kwon, Y.-M., Oh, S., Hwang, S.-S., Lee, C. M., Kwon, H., & Chung, G. E. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.314 · Cited by 219 · see citing works

Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol

Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 219 · see citing works

Metabolic and Behavioral Characteristics of Metabolically Obese but Normal-Weight Women

Conus, F., Allison, D. B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D. H., Tremblay-Lebeau, A., & Poehlman, E. T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0265 · Cited by 215 · see citing works

Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease

江口, 有. (2006) · Medical Entomology and Zoology · Cited by 195 · see citing works

Nonalcoholic fatty liver disease

Erickson, S. K. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800089-jlr200 · Cited by 194 · see citing works

Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population

Dassanayake, A. S., Kasturiratne, A., Rajindrajith, S., Kalubowila, U., Chakrawarthi, S., Silva, A. P. D., Makaya, M., Mizoue, T., Kato, N., Wickremasinghe, A. R., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05831.x · Cited by 185 · see citing works

Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study

Xu, C., Yu, C., Ma, H., Xu, L., Miao, M., & Li, Y. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.104 · Cited by 183 · see citing works

A fresh look at NASH pathogenesis. Part 1: The metabolic movers

Larter, C. Z., Chitturi, S., Heydet, D., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06253.x · Cited by 178 · see citing works

Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease

Kim, D., Chung, G. E., Kwak, M., Seo, H. B., Kang, J. H., Kim, W. K., Kim, Y. J., Yoon, J., Lee, H.-S., & Kim, C. Y. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.024 · Cited by 175 · see citing works

Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy

Wong, V. W., Wong, G. L., Yeung, D. K., Lau, T. K., Chan, C. K.-M., Chim, A. M., Abrigo, J., Chan, R., Woo, J., Tse, Y., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.041 · Cited by 173 · see citing works

Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults

Bae, J. C., Suh, S., Park, S. E., Rhee, E., Park, C., Oh, K. W., Park, S. W., Kim, S. W., Hur, K. Y., Kim, J. H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046819 · Cited by 165 · see citing works

The Role of Diet and Nutrient Composition in Nonalcoholic Fatty Liver Disease

McCarthy, E. M., & Rinella, M. E. (2012) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jada.2011.10.007 · Cited by 162 · see citing works

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012

Nishioji, K., Sumida, Y., Kamaguchi, M., Mochizuki, N., Kobayashi, M., Nishimura, T., Yamaguchi, K., & Itoh, Y. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0948-9 · Cited by 161 · see citing works

PNPLA 3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease

Shen, J., Wong, G. L., Chan, H. L., Chan, R., Chan, H., Chu, C. W., Cheung, B., Yeung, D. K., Li, L. S., Sea, M. M.-M., et al. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12656 · Cited by 159 · see citing works

Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss–induced decrease in liver fat in humans

Sevastianova, K., Kotronen, A., Gastaldelli, A., Perttilä, J., Hakkarainen, A., Lundbom, J., Suojanen, L.-U., Orho‐Melander, M., Lundbom, N. M. I., Ferrannini, E., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.012369 · Cited by 158 · see citing works

Visceral adipose tissue area is an independent risk factor for hepatic steatosis

Park, B. J., Kim, Y. J., Kim, D., Kim, W. K., Jung, Y. J., Yoon, J., Kim, C. Y., Cho, Y. M., Kim, S. H., Lee, K. B., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05212.x · Cited by 154 · see citing works

379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease

Cruz, A. C. D., Bugianesi, E., George, J., Day, C. P., Liaquat, H., Charatcharoenwitthaya, P., Mills, P. R., Dam‐Larsen, S., Bjornsson, E. S., Hafliðadóttir, S., et al. (2014) · Gastroenterology · doi:10.1016/s0016-5085(14)63307-2 · Cited by 144 · see citing works

Correction

(2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.001 · Cited by 143 · see citing works

Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study

Lankarani, K. B., Ghaffarpasand, F., Mahmoodi, M., Lotfi, M., Zamiria, N., Heydari, S. T., Fallahzadeh, M. K., Maharlouei, N., Babaeinejad, M., Mehravar, S., et al. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.9248 · Cited by 139 · see citing works

Ultrasonographically Detected Non-Alcoholic Fatty Liver Disease Is an Independent Predictor for Identifying Patients With Insulin Resistance in Non-Obese, Non-Diabetic Middle-Aged Asian Adults

Sinn, D. H., Gwak, G., Park, H. N., Kim, J. E., Min, Y. W., Kim, K. M., Kim, Y. J., Choi, M. S., Lee, J. H., Koh, K. C., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.400 · Cited by 124 · see citing works

Metabolically healthy but obese individuals: relationship with hepatic enzymes

Messier, V., Karelis, A. D., Robillard, M.-È., Bellefeuille, P., Brochu, M., Lavoie, J.-M., & RABASA-LHORET, R. P. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.06.020 · Cited by 124 · see citing works

Validation of the NAFLD Fibrosis Score in a Chinese Population With Low Prevalence of Advanced Fibrosis

Wong, V. W., Wong, G. L., Chim, A. M., Tse, A. M. L., Tsang, S. W., Hui, A., Choi, P. C., Chan, A. W. H., So, W., Chan, F. K. L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01933.x · Cited by 123 · see citing works

Variations in BMI and Prevalence of Health Risks in Diverse Racial and Ethnic Populations

Stommel, M., & Schoenborn, C. A. (2010) · Obesity · doi:10.1038/oby.2009.472 · Cited by 122 · see citing works

Comparison of the Classification of Obesity by BMI vs. Dual‐energy X‐ray Absorptiometry in the Newfoundland Population

Kennedy, A. P., Shea, J. L., & Sun, G. (2009) · Obesity · doi:10.1038/oby.2009.101 · Cited by 115 · see citing works

Sagittal Abdominal Diameter Is a Strong Anthropometric Measure of Visceral Adipose Tissue in the Asian General Population

Yim, J. Y., Kim, D., Lim, S. H., Park, M., Choi, S. H., Lee, C. H., Kim, S. S., & Cho, S. (2010) · Diabetes Care · doi:10.2337/dc10-0606 · Cited by 115 · see citing works

PNPLA 3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome

Shen, J., Wong, G. L., Chan, H. L., Chan, H., Yeung, D. K. ‐., Chan, R., Chim, A. M.-L., Chan, A. W. H., Choi, P. C., Woo, J., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12609 · Cited by 114 · see citing works

Exercise and diet modification in non‐obese non‐alcoholic fatty liver disease: Analysis of biopsies of living liver donors

Jin, Y., Kim, K. M., Hwang, S., Lee, S. G., Ha, T., Song, G., Jung, D., Kim, K., Yu, E., Shim, J. H., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07165.x · Cited by 106 · see citing works

Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis

Kainuma, M., Fujimoto, M., SEKIYA, N., Tsuneyama, K., Cheng, C., Takano, Y., TERASAWA, K., & Shimada, Y. (2006) · Journal of Gastroenterology · doi:10.1007/s00535-006-1883-1 · Cited by 100 · see citing works

Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.

Vos, B., Moreno, C., Nagy, N., Féry, F., Cnop, M., Vereerstraeten, P., Deviere, J. M. E., & Adler, M. (2011) · PubMed · Cited by 99 · see citing works

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels

Akyüz, Ü., Yeşıl, A., & Yilmaz, Y. N. (2014) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2014.983160 · Cited by 97 · see citing works

The Prevalence of Metabolically Healthy Obese Subjects Defined by BMI and Dual‐Energy X‐Ray Absorptiometry

Shea, J. L., Randell, E. W., & Sun, G. (2010) · Obesity · doi:10.1038/oby.2010.174 · Cited by 94 · see citing works

Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol

Enjoji, M., Yasutake, K., Kohjima, M., & Nakamuta, M. (2012) · International Journal of Hepatology · doi:10.1155/2012/925807 · Cited by 85 · see citing works

NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease

Enjoji, M., Machida, K., Kohjima, M., Kato, M., Kotoh, K., Matsunaga, K., Nakashima, M., & Nakamuta, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-29 · Cited by 76 · see citing works

Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men

Chang, Y., Ryu, S., Sung, E., Woo, H.-Y., Cho, S.-I., Yoo, S.-H., Ahn, H.-Y., & Choi, N.-K. (2009) · Gut · doi:10.1136/gut.2008.161885 · Cited by 75 · see citing works

Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh

Alam, S., Gupta, U. D., Alam, M., Kabir, J., Chowdhury, Z. R., & Alam, A. K. M. K. (2014) · Indian Journal of Gastroenterology · doi:10.1007/s12664-014-0488-5 · Cited by 74 · see citing works

Nonalcoholic fatty liver disease as a component of the metabolic syndrome

Khashab, M. A., Liangpunsakul, S., & Chalasani, N. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0012-0 · Cited by 71 · see citing works

Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism

Musso, G., Cassader, M., Bo, S., Michieli, F. D., & Gambino, R. (2012) · Diabetes · doi:10.2337/db12-0858 · Cited by 70 · see citing works

Effect of Body Weight and Lifestyle Changes on Long-Term Course of Nonalcoholic Fatty Liver Disease in Koreans

Kim, H.-K., Park, J., Lee, K.-U., Lee, G., Jeon, S.-H., Kim, J.-H., & Kim, C. (2009) · American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181812879 · Cited by 61 · see citing works

The Risk Factors for Ultrasound-diagnosed Non-alcoholic Fatty Liver Disease Among Adolescents

Fu, C.-C., Chen, M.-C., Li, Y., Liu, T., & Wang, L. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n1p15 · Cited by 59 · see citing works

Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance

Kwak, M., Kim, D., Chung, G. E., Kim, W. K., Kim, Y. J., & Yoon, J. (2014) · Liver International · doi:10.1111/liv.12552 · Cited by 58 · see citing works

Editorial: Non-Alcoholic Fatty Liver Disease and Obesity: Not All About Body Mass Index

Pagadala, M. R., & McCullough, A. J. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.320 · Cited by 56 · see citing works

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

Enjoji (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000070 · Cited by 56 · see citing works

The Prevalence and Clinical Correlates of Nonalcoholic Fatty Liver Disease (NAFLD) in African Americans: The Multiethnic Study of Atherosclerosis (MESA)

Foster, T., Anania, F. A., Li, D., Katz, R., & Budoff, M. J. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2652-7 · Cited by 53 · see citing works

Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3

Lallukka, S., Sevastianova, K., Perttilä, J., Hakkarainen, A., Orho‐Melander, M., Lundbom, N. M. I., Olkkonen, V. M., & Yki-Järvinen, H. (2013) · Diabetologia · doi:10.1007/s00125-013-2829-9 · Cited by 53 · see citing works

Is visceral fat reduction necessary to favour metabolic changes in the liver?

Finelli, C., & Tarantino, G. (2012) · PubMed · Cited by 53 · see citing works

Exercise and fat accumulation in the human liver

Magkos, F. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32833ea912 · Cited by 51 · see citing works

The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease

Margariti, A., Deutsch, M. J., Manolakopoulos, S., TINIAKOS, D. G., & Papatheodoridis, G. (2013) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31826be328 · Cited by 47 · see citing works

Applicability of BARD score to Japanese patients with NAFLD

Fujii, H., Enomoto, M., Fukushima, W., Tamori, A., Sakaguchi, H., & Kawada, N. (2009) · Gut · doi:10.1136/gut.2009.182758 · Cited by 45 · see citing works

Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity

Adams, L. A., Marsh, J. A., Ayonrinde, O. T., Olynyk, J. K., Ang, W., Beilin, L. J., Mori, T. A., Palmer, L. J., Oddy, W. H., Lye, S. J., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07120.x · Cited by 43 · see citing works

Weight loss allows the dissection of the interaction between abdominal fat and PNPLA3 (adiponutrin) in the liver damage of obese children

Marzuillo, P., Grandone, A., Perrone, L., & del Giudice, E. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.027 · Cited by 41 · see citing works

Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease

Manco, M., Alisi, A., Real, J.-M. F., Equitani, F., Vito, R. D., Valenti, L. V. C., & Nobili, V. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.007 · Cited by 39 · see citing works

Metabolic Syndrome and Ectopic Fat Deposition

Meng, K., Lee, C. H., & Saremi, F. (2010) · Academic Radiology · doi:10.1016/j.acra.2010.03.019 · Cited by 34 · see citing works

Nonobese individuals in the developing world are at risk of nonalcoholic fatty liver and liver disease

Wood, N. J. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.95 · Cited by 23 · see citing works

Validation of P2/MS and Other Noninvasive Fibrosis Scoring Systems in the Korean Population with Nonalcoholic Fatty Liver Disease

Yu, S. J., Kim, D., Lee, J., Chung, G. E., Yim, J. Y., Park, M. J., Kim, Y. J., Yoon, J., Jang, J., & Lee, H.-S. (2011) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2011.57.1.19 · Cited by 13 · see citing works

Beyond obesity: Is cholesterol‐induced liver injury the cause of non‐alcoholic steatohepatitis?

Ioannou, G. N. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07196.x · Cited by 4 · see citing works

S1913 Visceral Fat As a Strong and Independent Risk Factor of Nonalcoholic Fatty Liver Disease

Kim, D., Park, B. J., Kim, W. K., Jung, Y. J., Kim, Y. J., Yoon, J., & Lee, H.-S. (2008) · Gastroenterology · doi:10.1016/s0016-5085(08)63655-0 · Cited by 4 · see citing works

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925 · see citing works

Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases

Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745 · see citing works

Molecular pathways of nonalcoholic fatty liver disease development and progression

Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 625 · see citing works

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Lee, G., You, H. J., Bajaj, J. S., Joo, S. K., Yu, J., Park, S., Kang, H., Park, J. H., Kim, J. H., Lee, D. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18754-5 · Cited by 395 · see citing works

Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease

Wong, V. W.-S., Wong, G. L.-H., Chan, R. S.-M., Shu, S. S.-T., Cheung, B. H.-K., Li, L. S., Chim, A. M.-L., Chan, C. K.-M., Leung, J. K.-Y., Chu, W. C.-W., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.011 · Cited by 319 · see citing works

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016

Zou, B., Yeo, Y. H., Nguyen, V. H., Cheung, R. C., Ingelsson, E., & Nguyen, M. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13069 · Cited by 250 · see citing works

Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies

Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 226 · see citing works

Intestinal Barrier and Permeability in Health, Obesity and NAFLD

Portincasa, P., Bonfrate, L., Khalil, M., Angelis, M. D., Calabrese, F. M., D’Amato, M., Wang, D. Q. ‐., & Ciaula, A. D. (2021) · Biomedicines · doi:10.3390/biomedicines10010083 · Cited by 212 · see citing works

Nonalcoholic fatty liver disease: Evolving paradigms

Lonardo, A., Nascimbeni, F., Maurantonio, M., Marrazzo, A., Rinaldi, L., & Adinolfi, L. E. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6571 · Cited by 197 · see citing works

Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview

Marchisello, S., Pino, A. D., Scicali, R., Urbano, F., Piro, S., Purrello, F., & Rabuazzo, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081948 · Cited by 194 · see citing works

Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease

Huh, Y., Cho, Y. J., & Nam, G. E. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes22021 · Cited by 176 · see citing works

Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study

Chang, Y., Ryu, S., Sung, K., Cho, Y. K., Sung, E., Kim, H., Jung, H. S., Yun, K. E., Ahn, J., Shin, H. C., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-317666 · Cited by 165 · see citing works

Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults

Lee, S. B., Kim, M. K., Kang, S., Park, K., Kim, J. H., Baik, S. J., Nam, J. S., Ahn, C. W., & Park, J. S. (2019) · Endocrinology and Metabolism · doi:10.3803/enm.2019.34.2.179 · Cited by 162 · see citing works

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169 · see citing works

Non-alcoholic Fatty Liver Disease: A Clinical Update

Pappachan, J. M., Babu, S. V., Krishnan, B., & Ravindran, N. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00013 · Cited by 157 · see citing works

Natural History of NAFLD/NASH

Ekstedt, M., Nasr, P., & Kechagias, S. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0378-2 · Cited by 141 · see citing works

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)

Drescher, H. K., Weiskirchen, S., & Weiskirchen, R. (2019) · Cells · doi:10.3390/cells8080845 · Cited by 134 · see citing works

Fatty liver index and hepatic steatosis index for prediction of non‐alcoholic fatty liver disease in type 1 diabetes

Sviklāne, L., Olmane, E., Dzērve, Z., Kupčs, K., Pīrāgs, V., & Sokolovska, J. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13814 · Cited by 133 · see citing works

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis

Wu, J., Yao, X.-Y., Shi, R.-X., Liu, S.-F., & Wang, X.-Y. (2018) · Reproductive Health · doi:10.1186/s12978-018-0519-2 · Cited by 130 · see citing works

Recent Epidemiology of Nonalcoholic Fatty Liver Disease

Murag, S., Ahmed, A., & Kim, D. (2020) · Gut and Liver · doi:10.5009/gnl20127 · Cited by 121 · see citing works

Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity

Kwak, M., & Kim, D. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.343 · Cited by 117 · see citing works

Global epidemiology of lean non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

Lu, F., Zheng, K. I., Rios, R. S., Targher, G., Byrne, C. D., & Zheng, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15156 · Cited by 116 · see citing works

CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease

Breuer, D., Pacheco, M. C., Washington, M. K., Montgomery, S. A., Hasty, A. H., & Kennedy, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00040.2019 · Cited by 112 · see citing works

Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond

Krawczyk, M. J., Liebe, R., & Lammert, F. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.053 · Cited by 110 · see citing works

Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities

Golabi, P., Paik, J. M., Arshad, T., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology Communications · doi:10.1002/hep4.1534 · Cited by 103 · see citing works

Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma

Lau, H. C.-H., Zhang, X., & Yu, J. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01089-1 · Cited by 112 · see citing works

Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross‐sectional analysis of 2011‐2014 National Health and Nutrition Examination Survey

Wong, R. J., Liu, B., & Bhuket, T. P. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14327 · Cited by 99 · see citing works

Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Houttu, V., Csader, S., Nieuwdorp, M., Holleboom, A. G., & Schwab, U. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.716783 · Cited by 95 · see citing works

Polycystic ovary syndrome with hyperandrogenism as a risk factor for non‐obese non‐alcoholic fatty liver disease

Kim, J. J., Kim, D., Yim, J. Y., Kang, J., Han, K., Kim, S. M., Hwang, K. R., Ku, S., Suh, C. S., Kim, S. H., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14058 · Cited by 94 · see citing works

Recent research trends and updates on nonalcoholic fatty liver disease

Yoo, J., Kim, W. K., Kim, M. Y., Jun, D. W., Kim, S. G., Yeon, J.-E., Lee, J. W., Cho, Y. K., Park, S. H., & Sohn, J. H. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2018.0037 · Cited by 92 · see citing works

Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices

Younossi, Z. M., Corey, K. E., Alkhouri, N., Noureddin, M., Jacobson, I. M., Lam, B. P., Clement, S. C., Basu, R., Gordon, S. C., Ravendhra, N., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15830 · Cited by 92 · see citing works

A review of non‐alcoholic fatty liver disease in non‐obese and lean individuals

Ahadi, M., Molooghi, K., Masoudifar, N., Namdar, A. B., Vossoughinia, H., & Farzanehfar, M. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15353 · Cited by 91 · see citing works

The Prevalence of Lean/Nonobese Nonalcoholic Fatty Liver Disease

Shi, Y., Wang, Q., Sun, Y., Zhao, X., Kong, Y., Ou, X., Jia, J., Wu, S., & You, H. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001270 · Cited by 89 · see citing works

The metabolic basis of nonalcoholic steatohepatitis

Chakravarthy, M. V., & Neuschwander‐Tetri, B. A. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.112 · Cited by 87 · see citing works

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease

Kim, Y., Han, E., Lee, J. S., Lee, H. W., Kim, B. K., Kim, M. K., Kim, H. S., Park, J. Y., Kim, D. Y., Ahn, S. H., et al. (2021) · Gut and Liver · doi:10.5009/gnl210084 · Cited by 87 · see citing works

Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects

Zhang, S., Du, T., Li, M., Jia, J., Lu, H., Lin, X., & Yu, X. (2017) · Medicine · doi:10.1097/md.0000000000007041 · Cited by 84 · see citing works

Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations

Danpanichkul, P., Suparan, K., Prasitsumrit, V., Ahmed, A., Wijarnpreecha, K., & Kim, D. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0631 · Cited by 84 · see citing works

Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota

Bluemel, S., Williams, B., Knight, R. D., & Schnabl, B. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2016 · Cited by 83 · see citing works

PM2.5 air pollution exposure and nonalcoholic fatty liver disease in the Nationwide Inpatient Sample

VoPham, T., Kim, N. J., Berry, K., Mendoza, J. A., Kaufman, J. D., & Ioannou, G. N. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113611 · Cited by 82 · see citing works

Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?

Riazi, K., Raman, M., Taylor, L., Swain, M. G., & Shaheen, A. A. (2019) · Nutrients · doi:10.3390/nu11122878 · Cited by 83 · see citing works

Association of genetic variations with NAFLD in lean individuals

Lin, H., Wong, G. L., Whatling, C. A., Chan, A. W. H., Leung, H. H. W., Tse, C., Shu, S. S., Chim, A. M.-L., Lai, J. C., Yip, T. C., et al. (2021) · Liver International · doi:10.1111/liv.15078 · Cited by 80 · see citing works

Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Kim, Y., Chang, Y., Cho, Y. K., Ahn, J., Shin, H. C., & Ryu, S. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.006 · Cited by 80 · see citing works

LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study

Zou, Y., Zhong, L., Hu, C., Zhong, M., Peng, N., & Sheng, G. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01457-1 · Cited by 79 · see citing works

Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression

Tirosh, O. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2548154 · Cited by 77 · see citing works

Lean NAFLD: an underrecognized and challenging disorder in medicine

Maier, S., Wieland, A. C., Cree‐Green, M., Nadeau, K. J., Sullivan, S. A., Lanaspa, M. A., Johnson, R. J., & Jensen, T. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09621-1 · Cited by 77 · see citing works

Health and Prevention Enhancement (H-PEACE): a retrospective, population-based cohort study conducted at the Seoul National University Hospital Gangnam Center, Korea

Lee, C., Choe, E. K., Choi, J. M., Hwang, Y., Lee, Y., Park, B., Chung, S. J., Kwak, M., Lee, J.-E., Kim, J. S., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-019327 · Cited by 75 · see citing works

Escherichia fergusonii Promotes Nonobese Nonalcoholic Fatty Liver Disease by Interfering With Host Hepatic Lipid Metabolism Through Its Own msRNA 23487

Xin, F., Zhao, Z., Liu, X., Pan, Q., Wang, Z., Zeng, L., Zhang, Q., Ye, L., Wang, M., Zhang, R.-N., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.12.003 · Cited by 75 · see citing works

Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study

Chang, Y., Cho, Y. K., Cho, J., Jung, H.-S., Yun, K. E., Ahn, J., Sohn, C. I., Shin, H. C., & Ryu, S. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000074 · Cited by 74 · see citing works

Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis

Chang, Y., Ryu, S., Kim, Y., Cho, Y. K., Sung, E., Kim, H., Ahn, J., Jung, H. S., Yun, K. E., Kim, S., et al. (2019) · Hepatology · doi:10.1002/hep.30867 · Cited by 73 · see citing works

Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA

Wijarnpreecha, K., Kim, D., Raymond, P., Scribani, M., & Ahmed, A. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001397 · Cited by 71 · see citing works

Nonalcoholic fatty liver disease or metabolic dysfunction‐associated fatty liver disease diagnoses and cardiovascular diseases: From epidemiology to drug approaches

Dongiovanni, P., Paolini, E., Corsini, A., Sirtori, C. R., & Ruscica, M. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13519 · Cited by 70 · see citing works

The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review

Dufour, J., Scherer, R., Balp, M., McKenna, S. J., Janssens, N., Lopez, P., & Pedrosa, M. C. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100089 · Cited by 70 · see citing works

Environmental Risk Factors for Liver Cancer and Nonalcoholic Fatty Liver Disease

VoPham, T. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-0183-2 · Cited by 68 · see citing works

Characteristics of non‐alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign

Tobari, M., Hashimoto, E., Taniai, M., 五十嵐悠一, Kodama, K., Kogiso, T., Tokushige, K., Nishino, T., & Hashimoto, N. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14585 · Cited by 66 · see citing works

The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults

Li, H., Zhang, Y., Luo, H., & Lin, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.977625 · Cited by 65 · see citing works

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)

Spremović-Radjenović, S., Pupovac, M., Andjić, M., Bila, J. S., Sreckovic, S. D., Gudović, A., Dragaš, B., & Radunović, N. V. (2022) · Biomedicines · doi:10.3390/biomedicines10010131 · Cited by 64 · see citing works

Fatty liver and FGF21 physiology

Maratos–Flier, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.006 · Cited by 64 · see citing works

Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index

Tobari, M., & Hashimoto, E. (2019) · Gut and Liver · doi:10.5009/gnl19236 · Cited by 64 · see citing works

Ethnic Disparities in Adiposity: Focus on Nonalcoholic Fatty Liver Disease, Visceral, and Generalized Obesity

Agbim, U., Carr, R., Pickett-Blakely, O., & Dagogo-Jack, S. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00349-x · Cited by 56 · see citing works

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study

Tan, E., Lee, J. W. J., Jumat, N. H. B., Chan, W., Treeprasertsuk, S., Goh, G. B., Fan, J.-G., Song, M. J., Charatcharoenwitthaya, P., Duseja, A. K., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154911 · Cited by 62 · see citing works

Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?

Glass, L. M., Hunt, C. M., Fuchs, M. A., & Su, G. L. (2019) · Europe PMC (PubMed Central) · Cited by 62 · see citing works

Nonalcoholic Fatty Liver Disease: A Global Perspective

Wong, W., & Chan, W. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.01.007 · Cited by 61 · see citing works

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity

Kim, H., Bae, S., Lee, M. J., Kim, E. H., Park, H., Kim, H. S., Cho, Y. K., Jung, C. H., Lee, W. J., & Choe, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0035 · Cited by 61 · see citing works

Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults

Zhang, Y., Wang, Q., Chen, Y.-S., Shen, C., & Xu, C. (2020) · International Journal of Endocrinology · doi:10.1155/2020/5953461 · Cited by 60 · see citing works

Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?

Cordeiro, A., Costa, R., Andrade, N., Silva, C., Canabrava, N., Pena, M. J., Rodrigues, I., Andrade, S., & Ramalho, A. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.10.001 · Cited by 60 · see citing works

Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction

Chung, G. E., Lee, J., Lee, H., Kim, M. K., Yim, J. Y., Choi, S., Kim, Y. J., Yoon, J., & Kim, D. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.03.027 · Cited by 59 · see citing works

Insulin resistance is associated with elevated transaminases and low aspartate aminotransferase/alanine aminotransferase ratio in young adults with normal weight

Simental‐Mendía, L. E., Rodríguez‐Morán, M., Gómez-Díaz, R. A., Wacher, N. H., Rodríguez-Hernández, H., & Guerrero‐Romero, F. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000811 · Cited by 57 · see citing works

Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study

Li, Y., Zheng, R., Li, J., Feng, S., Wang, L., & Huang, Z. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01409-1 · Cited by 56 · see citing works

Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus

Cho, H. J., Hwang, S. H., Park, J. I., Yang, M. J., Hwang, J. C., Yoo, B. M., Lee, K. M., Shin, S. J., Lee, K. J., Kim, J. H., et al. (2019) · Gut and Liver · doi:10.5009/gnl18382 · Cited by 56 · see citing works

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease

Dallio, M., Diano, N., Masarone, M., Gravina, A. G., Patanè, V., Romeo, M., Sarno, R. D., Errico, S., Nicolucci, C., Abenavoli, L., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173134 · Cited by 56 · see citing works

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Baumann, A., Burger, K., Brandt, A., Staltner, R., Jung, F., Rajcic, D., Pisarello, M. J. L., & Bergheim, I. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155233 · Cited by 55 · see citing works

Predictors of nonalcoholic steatohepatitis and significant fibrosis in non‐obese nonalcoholic fatty liver disease

Kim, D., Kim, W. K., Joo, S. K., Kim, J. H., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2018) · Liver International · doi:10.1111/liv.13983 · Cited by 55 · see citing works

The Ameliorative Effects of Saikosaponin in Thioacetamide-Induced Liver Injury and Non-Alcoholic Fatty Liver Disease in Mice

Chang, G., Lin, W., Lin, T.-C., Liao, H.-J., & Lu, Y.-W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111383 · Cited by 56 · see citing works

Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms

Szilagyi, A. (2019) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-019-01037-y · Cited by 54 · see citing works

Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort

Singh, A., Dhaliwal, A., Singh, S., Kumar, A., López, R., Gupta, M., Noureddin, M., Carey, W., McCullough, A. J., & Alkhouri, N. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05700-9 · Cited by 53 · see citing works

Higher serum uric acid to HDL-cholesterol ratio is associated with onset of non-alcoholic fatty liver disease in a non-obese Chinese population with normal blood lipid levels

Zhu, W., Liang, A., Shi, P., Yuan, S., Zhu, Y., Fu, J., Zheng, T., Wen, Z., & Wu, X. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02263-4 · Cited by 51 · see citing works

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management

Chrysavgis, L., Ztriva, E., Protopapas, A. A., Τζιόμαλος, Κ., & Cholongitas, Ε. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i42.6514 · Cited by 53 · see citing works

Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States

Selvakumar, P. K. C., Kabbany, M. N., López, R., Rayas, M. S., Lynch, J. L., & Alkhouri, N. (2018) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001974 · Cited by 50 · see citing works

In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia

Hüttl, M., Marková, I., Miklánková, D., Zapletalová, I., Poruba, M., Haluzı́k, M., Vaněčková, I., & Malínská, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111513 · Cited by 51 · see citing works

Body composition and cardiometabolic health: the need for novel concepts

Bosy‐Westphal, A., Braun, W., Geisler, C., Norman, K., & Müller, M. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0158-2 · Cited by 49 · see citing works

Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)

Johnston, M. P., Patel, J. A., & Byrne, C. D. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200128094231 · Cited by 49 · see citing works

Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles

Zou, Z., Wong, V. W., & Fan, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12871 · Cited by 49 · see citing works

A human liver chimeric mouse model for non-alcoholic fatty liver disease

Bissig-Choisat, B., Alves-Bezerra, M., Zorman, B., Ochsner, S. A., Barzi, M., Legras, X., Yang, D., Borowiak, M., Dean, A. M., York, R. B., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100281 · Cited by 49 · see citing works

Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study

Zou, Y., Yu, M., & Sheng, G. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01326-3 · Cited by 48 · see citing works

Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient

Alam, S., Hasan, M. J., Khan, M. A. S., Alam, M., & Hasan, N. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0023 · Cited by 46 · see citing works

Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study

Cai, X., Gao, J. S., Hu, J., Wen, W., Zhu, Q., Wang, M., Liu, S., Hong, J., Wu, T., Yang, S., et al. (2022) · Disease Markers · doi:10.1155/2022/4930355 · Cited by 46 · see citing works

Lean nonalcoholic fatty liver disease and sarcopenia

Chen, M., Cao, Y. Y., Ji, G., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217249 · Cited by 45 · see citing works

Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population

Zeng, P., Cai, X., Yu, X., & Gong, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-47269-4 · Cited by 45 · see citing works

Association of Dimethylguanidino Valeric Acid With Partial Resistance to Metabolic Health Benefits of Regular Exercise

Robbins, J., Herzig, M. S., Morningstar, J. E., Sarzynski, M. A., Cruz, D. E., Wang, T. J., Gao, Y. L., Wilson, J. G., Bouchard, C., Rankinen, T., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1573 · Cited by 44 · see citing works

Dietary chia seeds (Salvia hispanica) improve acute dyslipidemia and steatohepatitis in rats

Fernández‐Martínez, E., Lira‐Islas, I. G., Cariño‐Cortés, R., Soria-Jasso, L. E., Pérez‐Hernández, E., & Pérez‐Hernández, N. (2019) · Journal of Food Biochemistry · doi:10.1111/jfbc.12986 · Cited by 45 · see citing works

Clinical and anthropometric characteristics of non‐obese non‐alcoholic fatty liver disease subjects in Japan

Shida, T., Oshida, N., Suzuki, H., Okada, K., Watahiki, T., Oh, S., Kim, T., Isobe, T., Okamoto, Y., Ariizumi, S., et al. (2020) · Hepatology Research · doi:10.1111/hepr.13543 · Cited by 45 · see citing works

Interleukin-17 Weakens the NAFLD/NASH Process by Facilitating Intestinal Barrier Restoration Depending on the Gut Microbiota

He, S., Cui, S., Song, W., Jiang, Y., Chen, H., Liao, D., Lu, X., Li, J., Chen, X., & Peng, L. (2022) · mBio · doi:10.1128/mbio.03688-21 · Cited by 46 · see citing works

Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma

Huang, Y., Chan, C., Lee, H. W., Huang, C., Chen, Y., Liu, P.-C., Lu, S., Chuang, W., Huang, J., Yu, M., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.046 · Cited by 44 · see citing works

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter

Lee, H. W., Kim, K. J., Jung, K. S., Chon, Y. E., Huh, J. H., Park, K. H., Chung, J. B., Kim, C. O., Han, K., & Park, J. Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187066 · Cited by 44 · see citing works

Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men

Choi, Y. J., Lee, D. H., Han, K.-D., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201308 · Cited by 44 · see citing works

Consenso mexicano de la enfermedad por hígado graso no alcohólico

Bernal-Reyes, R., Castro‐Narro, G., Malé-Velázquez, R., Carmona-Sánchez, R., González-Huezo, M. S., García-Juárez, I., Chávez-Tapia, N. C., Aguilar-Salinas, C., Aiza-Haddad, I., Ballesteros-Amozurrutia, M. A., et al. (2019) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2018.11.007 · Cited by 44 · see citing works

Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect

Heda, R. P., Yazawa, M., Shi, M. Y., Bhaskaran, M. C., Aloor, F. Z., Thuluvath, P. J., & Satapathy, S. K. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i17.1864 · Cited by 44 · see citing works

The role of microbiota in nonalcoholic fatty liver disease

Ciaula, A. D., Bonfrate, L., & Portincasa, P. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13768 · Cited by 43 · see citing works

Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients

Yousef, M., Juboori, A. A., Albarrak, A. A., Ibdah, J. A., & Tahan, V. (2017) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v8.i3.100 · Cited by 27 · see citing works

[Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases].

Chen, H., & Zhou, Y. (2020) · PubMed · doi:10.3760/cma.j.cn501113-20191226-00480

Nonobese nonalcoholic fatty liver disease

Aby, E. S., & Saab, S. (2017) · Clinical Liver Disease · doi:10.1002/cld.674 · Cited by 7 · see citing works

Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population

Lee, S., Lee, T., Yang, S., Tung, C.-F., Yeh, H., & Chang, C. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.01.007 · Cited by 36 · see citing works

Non-alcoholic Fatty Liver Disease in Non-obese Patients

Schmoyer, C. J., & Siddiqui, M. S. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0377-3 · Cited by 1 · see citing works